Key result
pHERV-W ENV expression changes positively correlate with EBV viral load variations in RRMS patients.
Why the study?
HERV-W envelope proteins and herpesviruses like EBV and HHV-6A/B are linked to multiple sclerosis, but the relationship between viral parameters and pHERV-W ENV/syncytin-1 expression remained unclear.
Cohort (n=98)
In RRMS patients, variations in EBV viral load correlate positively with pHERV-W ENV gene expression over 12 months, supporting the hypothesis of transactivation of pHERV-W ENV by EBV.
pHERV-W ENV and syncytin-1, the envelope proteins of the human endogenous retrovirus W family (HERV-W), have been proposed as etiological factors for MS development. In addition, herpesviruses, such as the Epstein-Barr virus (EBV) and the human herpesvirus 6A/B (HHV-6A/B), have been also strongly associated with the disease. This work aims to study the possible link between viral loads and antibody titers against EBV and HHV-6A/B and the pHERV-W ENV/syncytin-1 protein/gene expression. For this purpose, we conducted a 12-month longitudinal study involving 98 RRMS patients. Peripheral blood samples were obtained from each patient. Serum antibody titers against EBV and HHV-6A/B were determined by ELISA, while viral loads were analyzed using qPCR. HLA MS-related alleles were also genotyped. pHERV-W ENV/syncytin-1 protein and gene expression levels in immune cells were assessed by flow cytometry and qPCR, respectively. We found that the 12-month variation of the pHERV-W ENV gene expression levels positively correlated with the variation of the EBV viral load, especially in those patients with high baseline EBV loads. Therefore, these results could support previous studies pointing to the transactivation of pHERV-W ENV by EBV. However, further studies are needed to better understand this possible relationship.
No takes yet. Share an insight, caveat, or question.
Pérez‐Pérez et al. (2022) conducted a cohort in Relapsing-Remitting Multiple Sclerosis (RRMS) (n=98). EBV and HHV-6A/B viral loads and antibody titers was evaluated on Correlation between viral loads and antibody titers against EBV and HHV-6A/B and pHERV-W ENV/syncytin-1 protein/gene expression. The 12-month variation of pHERV-W ENV gene expression levels positively correlated with the variation of EBV viral load in RRMS patients, especially those with high baseline EBV loads.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: